INVESTIGATION ALERT: Fields Kupka & Shukurov LLP Is Investigating Vaxart, Inc. for Potential Breach of Fiduciary Duty Claims
Vaxart, Inc. (VXRT)
Last vaxart, inc. earnings: 3/19 04:01 pm
Check Earnings Report
Company Research
Source: GlobeNewswire
NEW YORK, April 27, 2020 (GLOBE NEWSWIRE) -- Fields Kupka & Shukurov LLP is investigating potential breach of fiduciary duty claims involving the board of directors of Vaxart, Inc. (NASDAQ: VXRT). If you are a shareholder of Vaxart, Inc. and wish to receive additional information, free of charge, please visit us at: https://fksfirm.com/investigation-vaxart-inc/ or contact William J. Fields, via email at wfields@fksfirm.com or by phone at (212) 231-1500. We will speak with you at no cost or obligation to you. Fields Kupka & Shukurov LLP is a law firm which represents victims of securities fraud, breaches of fiduciary duty, or other corporate misconduct. For more information about us, please visit our website at www.fksfirm.com. Attorney Advertising. Prior results do not guarantee a similar outcome. Fields Kupka & Shukurov LLPWilliam J. Fields1370 Broadway5th Floor – #5100New York, NY 10018Tel: (212) 231-1500Fax: (646) 851-0076 www.fksfirm.com Source: Fields Kupka & Shukurov LLP
Show less
Read more
Impact Snapshot
Event Time:
VXRT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
VXRT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
VXRT alerts
High impacting Vaxart, Inc. news events
Weekly update
A roundup of the hottest topics
VXRT
News
- Vaxart, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)GlobeNewswire
- Vaxart Provides Business Update and Reports Third Quarter 2024 Financial ResultsGlobeNewswire
- Vaxart to Host Third Quarter 2024 Business Update and Financial Results Conference Call on November 13GlobeNewswire
- Vaxart to Showcase its COVID-19 and Norovirus Oral Pill Vaccine Candidates at World Vaccine Congress Europe 2024GlobeNewswire
- Vaxart to Present Norovirus Data at IDWeek 2024 Underscoring Commitment to Address Significant Unmet NeedGlobeNewswire
VXRT
Earnings
- 11/13/24 - Beat
VXRT
Sec Filings
- 11/13/24 - Form 10-Q
- 11/13/24 - Form 8-K
- 10/8/24 - Form 424B5
- VXRT's page on the SEC website